NCT05043402 2022-08-15A Study of Navicixizumab in Patients With Platinum Resistant Ovarian CancerOncXerna Theraputics, Inc.Phase 3 Unknown400 enrolled
NCT03030287 2020-09-03A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube CancerMereo BioPharmaPhase 1 Completed44 enrolled